Publicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (9)

2013

  1. Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging

    Aging Cell, Vol. 12, Núm. 1, pp. 102-111

2011

  1. Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 11, pp. 2455-2463

2010

  1. Control of cell proliferation in atherosclerosis: Insights from animal models and human studies

    Cardiovascular Research, Vol. 86, Núm. 2, pp. 254-264

  2. Pathophysiology of the proatherothrombotic state in the metabolic syndrome

    Frontiers in Bioscience - Scholar, Vol. 2 S, Núm. 1, pp. 194-208

  3. p19ARF Deficiency Reduces Macrophage and Vascular Smooth Muscle Cell Apoptosis and Aggravates Atherosclerosis

    Journal of the American College of Cardiology, Vol. 55, Núm. 20, pp. 2258-2268

2008

  1. Molecular mechanisms of atherosclerosis in metabolic syndrome: Role of reduced IRS2-dependent signaling

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 28, Núm. 12, pp. 2187-2194

2007

  1. Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis

    Frontiers in Bioscience, Vol. 12, Núm. 12, pp. 4439-4455

  2. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice

    Frontiers in Bioscience, Vol. 12, Núm. 6, pp. 2291-2298

2006

  1. Atheroma development in apolipoprotein E-null mice is not affected by partial inactivation of PTEN

    Frontiers in Bioscience, Vol. 11, Núm. SUPPL. 2, pp. 2739-2745